Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity | 14 | 2016 | 837 | 1.010 |
Why?
|
| Herpes Zoster | 8 | 2020 | 82 | 0.820 |
Why?
|
| Ankle Brachial Index | 1 | 2018 | 8 | 0.620 |
Why?
|
| Vascular Calcification | 1 | 2018 | 9 | 0.620 |
Why?
|
| C-Reactive Protein | 1 | 2018 | 58 | 0.610 |
Why?
|
| Body Weight | 7 | 2013 | 219 | 0.590 |
Why?
|
| Coronary Artery Disease | 1 | 2018 | 134 | 0.570 |
Why?
|
| Risk Assessment | 4 | 2018 | 1097 | 0.510 |
Why?
|
| Cardiovascular Diseases | 2 | 2018 | 598 | 0.490 |
Why?
|
| Continental Population Groups | 4 | 2013 | 302 | 0.440 |
Why?
|
| Child | 21 | 2020 | 2474 | 0.430 |
Why?
|
| Adolescent | 22 | 2020 | 3651 | 0.400 |
Why?
|
| Body Height | 3 | 2010 | 62 | 0.390 |
Why?
|
| Humans | 37 | 2020 | 17611 | 0.380 |
Why?
|
| Herpes Zoster Vaccine | 4 | 2013 | 59 | 0.370 |
Why?
|
| Birth Certificates | 1 | 2010 | 22 | 0.370 |
Why?
|
| Female | 33 | 2020 | 12608 | 0.370 |
Why?
|
| California | 18 | 2013 | 2284 | 0.360 |
Why?
|
| Ethnic Groups | 2 | 2011 | 485 | 0.360 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2010 | 85 | 0.350 |
Why?
|
| Child, Preschool | 14 | 2019 | 1409 | 0.350 |
Why?
|
| Male | 26 | 2020 | 10008 | 0.320 |
Why?
|
| Young Adult | 17 | 2020 | 2427 | 0.310 |
Why?
|
| Infant | 9 | 2020 | 1171 | 0.310 |
Why?
|
| Overweight | 5 | 2016 | 269 | 0.310 |
Why?
|
| Prevalence | 12 | 2013 | 884 | 0.300 |
Why?
|
| Vaccination | 5 | 2020 | 635 | 0.290 |
Why?
|
| Electronic Health Records | 3 | 2020 | 681 | 0.290 |
Why?
|
| Prenatal Care | 2 | 2020 | 128 | 0.280 |
Why?
|
| Adult | 15 | 2020 | 7598 | 0.260 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2019 | 136 | 0.260 |
Why?
|
| Body Mass Index | 9 | 2013 | 958 | 0.250 |
Why?
|
| Chickenpox Vaccine | 4 | 2020 | 91 | 0.240 |
Why?
|
| Preventive Health Services | 2 | 2016 | 159 | 0.230 |
Why?
|
| Hypertension | 3 | 2013 | 500 | 0.230 |
Why?
|
| Weight Loss | 2 | 2020 | 303 | 0.230 |
Why?
|
| Kidney Failure, Chronic | 2 | 2018 | 147 | 0.230 |
Why?
|
| Retrospective Studies | 12 | 2020 | 2447 | 0.230 |
Why?
|
| Weight Reduction Programs | 2 | 2016 | 52 | 0.220 |
Why?
|
| Infant, Newborn | 4 | 2019 | 844 | 0.220 |
Why?
|
| Risk Factors | 9 | 2018 | 3325 | 0.210 |
Why?
|
| Cross-Sectional Studies | 11 | 2013 | 1322 | 0.210 |
Why?
|
| Cohort Studies | 12 | 2020 | 2570 | 0.210 |
Why?
|
| Psoriasis | 2 | 2011 | 9 | 0.190 |
Why?
|
| Papillomavirus Infections | 2 | 2020 | 133 | 0.180 |
Why?
|
| Hispanic Americans | 3 | 2012 | 404 | 0.180 |
Why?
|
| Incidence | 7 | 2020 | 1255 | 0.180 |
Why?
|
| Mumps | 1 | 2020 | 12 | 0.180 |
Why?
|
| Condylomata Acuminata | 1 | 2020 | 23 | 0.170 |
Why?
|
| Chickenpox | 1 | 2020 | 35 | 0.170 |
Why?
|
| Clinical Trials as Topic | 2 | 2018 | 130 | 0.170 |
Why?
|
| Measles | 1 | 2020 | 24 | 0.170 |
Why?
|
| Hepatitis A Virus, Human | 1 | 2019 | 5 | 0.170 |
Why?
|
| Hepatitis A | 1 | 2019 | 10 | 0.170 |
Why?
|
| Hepatitis A Vaccines | 1 | 2019 | 14 | 0.170 |
Why?
|
| Papillomavirus Vaccines | 1 | 2020 | 113 | 0.160 |
Why?
|
| Odds Ratio | 4 | 2018 | 671 | 0.150 |
Why?
|
| Hepatitis B Vaccines | 1 | 2018 | 43 | 0.150 |
Why?
|
| Central Venous Catheters | 1 | 2018 | 4 | 0.150 |
Why?
|
| Catheterization, Central Venous | 1 | 2018 | 12 | 0.150 |
Why?
|
| African Americans | 2 | 2012 | 472 | 0.150 |
Why?
|
| Proteinuria | 1 | 2018 | 26 | 0.150 |
Why?
|
| Renal Dialysis | 1 | 2018 | 54 | 0.150 |
Why?
|
| Biomarkers | 1 | 2018 | 301 | 0.140 |
Why?
|
| Antibodies, Viral | 2 | 2020 | 65 | 0.130 |
Why?
|
| Preconception Care | 1 | 2016 | 43 | 0.130 |
Why?
|
| Contraceptives, Oral | 2 | 2013 | 26 | 0.130 |
Why?
|
| Pregnancy | 5 | 2020 | 1494 | 0.130 |
Why?
|
| Dental Care | 1 | 2015 | 19 | 0.130 |
Why?
|
| Middle Aged | 10 | 2019 | 7911 | 0.130 |
Why?
|
| Datasets as Topic | 1 | 2015 | 17 | 0.130 |
Why?
|
| Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | 1 | 2015 | 32 | 0.130 |
Why?
|
| Socioeconomic Factors | 3 | 2013 | 630 | 0.130 |
Why?
|
| Advisory Committees | 1 | 2016 | 110 | 0.120 |
Why?
|
| Adenoma | 1 | 2016 | 93 | 0.120 |
Why?
|
| Venous Thromboembolism | 1 | 2015 | 52 | 0.120 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2015 | 107 | 0.120 |
Why?
|
| Metabolic Syndrome | 2 | 2012 | 80 | 0.120 |
Why?
|
| Managed Care Programs | 2 | 2013 | 325 | 0.120 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 196 | 0.110 |
Why?
|
| United States | 7 | 2019 | 3956 | 0.110 |
Why?
|
| Prehypertension | 1 | 2013 | 22 | 0.110 |
Why?
|
| Lower Extremity | 1 | 2013 | 12 | 0.110 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2013 | 19 | 0.110 |
Why?
|
| Prepaid Health Plans | 2 | 2010 | 20 | 0.110 |
Why?
|
| Phosphorus | 1 | 2013 | 6 | 0.110 |
Why?
|
| Predictive Value of Tests | 2 | 2011 | 351 | 0.110 |
Why?
|
| Drug Utilization | 1 | 2013 | 127 | 0.110 |
Why?
|
| Gallstones | 1 | 2012 | 14 | 0.100 |
Why?
|
| Kidney | 1 | 2013 | 52 | 0.100 |
Why?
|
| Arm Injuries | 1 | 2012 | 4 | 0.100 |
Why?
|
| Aged | 8 | 2018 | 6095 | 0.100 |
Why?
|
| Leg Injuries | 1 | 2012 | 8 | 0.100 |
Why?
|
| Influenza Vaccines | 1 | 2015 | 267 | 0.100 |
Why?
|
| Contraception | 1 | 2012 | 25 | 0.100 |
Why?
|
| Influenza, Human | 1 | 2015 | 263 | 0.100 |
Why?
|
| Fractures, Bone | 1 | 2013 | 91 | 0.100 |
Why?
|
| Decision Making, Computer-Assisted | 1 | 2012 | 7 | 0.100 |
Why?
|
| Musculoskeletal Pain | 1 | 2012 | 27 | 0.100 |
Why?
|
| Censuses | 1 | 2012 | 31 | 0.100 |
Why?
|
| Dyslipidemias | 1 | 2012 | 62 | 0.100 |
Why?
|
| Health Planning | 1 | 2010 | 16 | 0.090 |
Why?
|
| Asian Americans | 1 | 2012 | 176 | 0.090 |
Why?
|
| Quality Control | 1 | 2010 | 45 | 0.090 |
Why?
|
| Lipids | 1 | 2011 | 77 | 0.090 |
Why?
|
| Guideline Adherence | 1 | 2012 | 155 | 0.090 |
Why?
|
| Patient Selection | 1 | 2012 | 190 | 0.090 |
Why?
|
| Pneumococcal Vaccines | 1 | 2011 | 64 | 0.090 |
Why?
|
| Catchment Area (Health) | 1 | 2010 | 8 | 0.090 |
Why?
|
| Confidence Intervals | 1 | 2010 | 237 | 0.090 |
Why?
|
| Colorectal Neoplasms | 1 | 2016 | 613 | 0.090 |
Why?
|
| Health Surveys | 1 | 2011 | 260 | 0.090 |
Why?
|
| Gastroesophageal Reflux | 1 | 2010 | 79 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 1 | 2012 | 318 | 0.080 |
Why?
|
| European Continental Ancestry Group | 1 | 2012 | 529 | 0.080 |
Why?
|
| Pregnancy Outcome | 2 | 2020 | 154 | 0.080 |
Why?
|
| Asthma | 1 | 2012 | 385 | 0.080 |
Why?
|
| Healthcare Disparities | 1 | 2010 | 201 | 0.080 |
Why?
|
| Mass Screening | 1 | 2013 | 661 | 0.080 |
Why?
|
| Health Status | 1 | 2010 | 298 | 0.080 |
Why?
|
| Logistic Models | 3 | 2018 | 926 | 0.070 |
Why?
|
| Delivery of Health Care | 1 | 2010 | 415 | 0.070 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2012 | 531 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 748 | 0.060 |
Why?
|
| Severity of Illness Index | 3 | 2011 | 454 | 0.060 |
Why?
|
| Regression Analysis | 2 | 2015 | 297 | 0.060 |
Why?
|
| Immunocompetence | 2 | 2012 | 10 | 0.050 |
Why?
|
| Comorbidity | 2 | 2013 | 594 | 0.050 |
Why?
|
| Pregnancy Trimesters | 1 | 2020 | 30 | 0.040 |
Why?
|
| Alphapapillomavirus | 1 | 2020 | 13 | 0.040 |
Why?
|
| Northwestern United States | 1 | 2020 | 53 | 0.040 |
Why?
|
| Vaccines, Combined | 1 | 2020 | 80 | 0.040 |
Why?
|
| Proportional Hazards Models | 2 | 2013 | 709 | 0.040 |
Why?
|
| Measles-Mumps-Rubella Vaccine | 1 | 2020 | 62 | 0.040 |
Why?
|
| Public Health Surveillance | 1 | 2019 | 42 | 0.040 |
Why?
|
| Mass Vaccination | 1 | 2019 | 22 | 0.040 |
Why?
|
| Sex Factors | 2 | 2012 | 643 | 0.040 |
Why?
|
| Hepatitis B | 1 | 2018 | 42 | 0.040 |
Why?
|
| Age Factors | 2 | 2010 | 917 | 0.040 |
Why?
|
| Time Factors | 1 | 2020 | 1086 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2013 | 1900 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2020 | 1259 | 0.030 |
Why?
|
| Colonography, Computed Tomographic | 1 | 2016 | 10 | 0.030 |
Why?
|
| DNA | 1 | 2016 | 22 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2016 | 29 | 0.030 |
Why?
|
| Incidental Findings | 1 | 2016 | 26 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 44 | 0.030 |
Why?
|
| Fetal Macrosomia | 1 | 2016 | 26 | 0.030 |
Why?
|
| Sigmoidoscopy | 1 | 2016 | 65 | 0.030 |
Why?
|
| Data Accuracy | 1 | 2016 | 27 | 0.030 |
Why?
|
| Feces | 1 | 2016 | 80 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 304 | 0.030 |
Why?
|
| Seasons | 1 | 2015 | 102 | 0.030 |
Why?
|
| Propensity Score | 1 | 2015 | 85 | 0.030 |
Why?
|
| Occult Blood | 1 | 2016 | 153 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 322 | 0.030 |
Why?
|
| Weight Gain | 1 | 2016 | 173 | 0.030 |
Why?
|
| Quality Assurance, Health Care | 1 | 2015 | 169 | 0.030 |
Why?
|
| Outcome Assessment (Health Care) | 1 | 2015 | 228 | 0.030 |
Why?
|
| Colonoscopy | 1 | 2016 | 251 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 568 | 0.030 |
Why?
|
| Anthropometry | 1 | 2013 | 66 | 0.030 |
Why?
|
| Demography | 1 | 2013 | 101 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2013 | 159 | 0.030 |
Why?
|
| Social Class | 1 | 2013 | 120 | 0.030 |
Why?
|
| Reference Values | 1 | 2012 | 91 | 0.030 |
Why?
|
| Thinness | 1 | 2012 | 30 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2013 | 153 | 0.030 |
Why?
|
| Secondary Prevention | 1 | 2012 | 47 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2012 | 190 | 0.020 |
Why?
|
| Oceanic Ancestry Group | 1 | 2012 | 33 | 0.020 |
Why?
|
| Family Characteristics | 1 | 2012 | 54 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2012 | 68 | 0.020 |
Why?
|
| Income | 1 | 2012 | 90 | 0.020 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2012 | 85 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2011 | 21 | 0.020 |
Why?
|
| Educational Status | 1 | 2012 | 200 | 0.020 |
Why?
|
| Dermatology | 1 | 2011 | 6 | 0.020 |
Why?
|
| Arthritis, Psoriatic | 1 | 2011 | 5 | 0.020 |
Why?
|
| Phototherapy | 1 | 2011 | 22 | 0.020 |
Why?
|
| African Continental Ancestry Group | 1 | 2012 | 162 | 0.020 |
Why?
|
| Adolescent Development | 1 | 2011 | 11 | 0.020 |
Why?
|
| Age of Onset | 1 | 2011 | 79 | 0.020 |
Why?
|
| Data Collection | 1 | 2012 | 256 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 381 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 129 | 0.020 |
Why?
|
| Pneumococcal Infections | 1 | 2011 | 42 | 0.020 |
Why?
|
| Health Services Research | 1 | 2012 | 231 | 0.020 |
Why?
|
| Obesity, Morbid | 1 | 2012 | 120 | 0.020 |
Why?
|
| Poverty | 1 | 2012 | 166 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2011 | 85 | 0.020 |
Why?
|
| Child Development | 1 | 2011 | 54 | 0.020 |
Why?
|
| Virus Activation | 1 | 2010 | 6 | 0.020 |
Why?
|
| Herpesvirus 3, Human | 1 | 2010 | 44 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2012 | 248 | 0.020 |
Why?
|
| Pediatrics | 1 | 2011 | 158 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 358 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 1210 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2011 | 428 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2010 | 1115 | 0.020 |
Why?
|
| Primary Health Care | 1 | 2011 | 766 | 0.020 |
Why?
|
Concepts
(201)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(27)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_
-->